跳至主要内容
临床试验/ISRCTN55509212
ISRCTN55509212已完成未知

A feasibility study for a multi-centre, randomised controlled trial evaluating the effects of early administration of cryoprecipitate in major traumatic haemorrhage.

HS Blood and Transplant Service (UK)0 个研究点目标入组 40 人开始时间: 2012年9月13日最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Written informed consent or agreement is obtained before any study related activity
  • 2. The participant is judged to be 16 or above in UK and is affected by traumatic injury
  • 3. The participant is deemed by the attending clinician to have ongoing active haemorrhage on admission
  • AND REQUIRES
  • 4. Activation of the local major haemorrhage protocol for management of severe blood loss

排除标准

  • 1. The patient has been transferred from another hospital
  • 2. The trauma team leader deems the patient inappropriate for the trial i.e. injuries deemed to be incompatible with life
  • 3. More than 3 hours has elapsed from the time of injury

研究者

发起方
HS Blood and Transplant Service (UK)

相似试验